Bioblends Formulations Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 1440.98%
- Profit Growth -200.63%
- Ebitda -430.55%
- Net Worth -26.87%
- Total Assets 140.51%
About Bioblends Formulations
Bioblends Formulations Private Limited (BFPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 November 2018 (Six years and three months 24 days old ). Its registered office is in Karnal, Haryana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Seema and Kuldeep Singh serve as directors at the Company.
Company Details
- Location
Karnal, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85100HR2018PTC076757
- Company No.
076757
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Nov 2018
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Bioblends Formulations?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kuldeep Singh  | Director | 01-Nov-2018 | Current |
| Seema | Director | 01-Nov-2018 | Current |
Financial Performance of Bioblends Formulations.
Bioblends Formulations Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 1440.98% increase. The company also saw a substantial fall in profitability, with a 200.63% decrease in profit. The company's net worth observed a substantial decline by a decrease of 26.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bioblends Formulations?
Unlock access to Bioblends Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Argent Cooperation Producer Company LimitedKuldeep Singh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bioblends Formulations?
Unlock and access historical data on people associated with Bioblends Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bioblends Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioblends Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.